BOCA RATON, FL, June 9 /PRNewswire-FirstCall/ -- Stem Cell Assurance, one of the nation's first Companies to provide adult stem cell collection and banking service to the general adult population, today announced that the Company has begun its financial audit in readiness to complete its filing with the Securities and Exchange Commission. In line with the recent additions to the Board, the Company intends to file its form 10, attain its public reporting status with the SEC and immediately qualify for listing on the OTC Bulletin Boards as its first step of corporate progression. "It has always been part of our financial plan to rapidly gain listing on the OTC Bulletin Board," commented Richard. "It is in the best interest of our shareholders and provides an excellent trading platform from which to grow our financial base. The company's reporting progression is in line with our corporate plan, our new centers and expansion into the healthcare and beauty markets this quarter". Safe Harbor: This letter contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward-looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words "estimate," "anticipate," "expect," "believe," and similar expressions are intended to be forward-looking statements. DATASOURCE: Traxxec Ltd CONTACT: Investor Relations Contact: George Dubec, Stem Cell Assurance,(561) 362-4142, , http://www.stemcellassurance.com/

Copyright